Highly variable drug product [PK / PD]

posted by jag009  – NJ, 2013-02-07 16:22 (4533 d 04:30 ago) – Posting: # 9988
Views: 8,475

Hi Dr_Dan,

❝ Please keep in mind: HVD ≠ HVDP

❝ HVDPs are products in which the drug must not necessaribly be highly variable, but the product could be of poor pharmaceutical quality => high within-formulation variability!


Understood and totally agree. I was just curious on what basis one justifies the need for a full four way replicate design study. I just don't see it unless one has identified the issues based on 1) quality issue - variation observed from dissolution/content uniformity/etc etc 2) running a pilot test only 2x2 or full replicate study.

John

Complete thread:

UA Flag
Activity
 Admin contact
23,428 posts in 4,929 threads, 1,686 registered users;
95 visitors (0 registered, 95 guests [including 12 identified bots]).
Forum time: 21:52 CEST (Europe/Vienna)

No matter what side of the argument you are on,
you always find people on your side
that you wish were on the other.    Thomas Berger

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5